SCHEMBL7918883

SCHEMBL7918883

CN1CCCC1COC(=O)c1c[nH]c2ccccc12

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 6/20 0.61
CHRNA4 P43681 6/20 0.61
CHRNA7 P36544 5/20 0.61
CHRNA5 P30532 2/20 0.61
CYP2D6 P10635 2/20 0.58
ALDH1A1 P00352 1/20 0.58
CYP1A2 P05177 1/20 0.58
CYP2C9 P11712 1/20 0.58
TSHR P16473 1/20 0.58
THPO P40225 1/20 0.58
HTR4 Q13639 2/20 0.58
PMP22 Q01453 1/20 0.57
RAB9A P51151 2/20 0.57
NPC1 O15118 1/20 0.57
HTR6 P50406 4/20 0.57
GABRA1 P14867 1/20 0.54
GABRG2 P18507 1/20 0.54
GABRB3 P28472 1/20 0.54
GABRA3 P34903 1/20 0.54
GABRA2 P47869 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7918881 1.00 CHRNB2 (0.61) CHRNB2CHRNA4CHRNA7CHRNA5CYP2D6
SCHEMBL7271039 0.97 CYP2D6 (0.60) CHRNB2CHRNA4CHRNA7CHRNA5CYP2D6
SCHEMBL7269469 0.97 CYP2D6 (0.60) CHRNB2CHRNA4CHRNA7CHRNA5CYP2D6
SCHEMBL7269463 0.97 CYP2D6 (0.60) CHRNB2CHRNA4CHRNA7CHRNA5CYP2D6
SCHEMBL7277894 0.96 CYP2D6 (0.62) CHRNB2CHRNA4CHRNA7CHRNA5CYP2D6
SCHEMBL7299257 0.90 CYP2D6 (0.64) CHRNB2CHRNA4CHRNA7CYP2D6ALDH1A1
SCHEMBL7280163 0.88 CYP2D6 (0.64) CHRNB2CHRNA4CHRNA7CYP2D6ALDH1A1
SCHEMBL7269282 0.86 RAB9A (0.57) CHRNB2CHRNA4CHRNA7CYP2D6ALDH1A1
SCHEMBL7270870 0.86 RAB9A (0.62) CHRNB2CHRNA4CHRNA7CYP2D6ALDH1A1
SCHEMBL7276029 0.84 RAB9A (0.56) CHRNB2CHRNA4CHRNA7CYP2D6ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6221878-B1 ANTAGONISTS OF 5-HYDROXYTRYPTAMINE (5-HT) AT 5-HT3 RECEPTORS GLAXO GROUP LIMITED (GB) 2001-04-24 US disclosed
US-5420139-A Administering 4-amino-N-1-azabicyclo(2.2.2)oct-3-yl-5-chloro-2-methoxybenzamide GLAXO GROUP LIMITED (GB) 1995-05-30 US disclosed
US-5330982-A Promote gastric emptying GLAXO GROUP LIMITED (GB) 1994-07-19 US disclosed
US-5298510-A Relief of side effects resulting from drug withdrawal, treatment of addiction, indole derivatives GLAXO GROUP LIMITED (GB) 1994-03-29 US disclosed
US-5246941-A Serotonin antagonist GLAXO GROUP LIMITED (GB) 1993-09-21 US disclosed
US-5244909-A Methods for the treatment of cognitive disorders GLAXO GROUP LIMITED (GB) 1993-09-14 US disclosed
US-5200414-A Adiminstering endo-N-(8-methyl-8-azabicyclooct-3-yl)-2,3-dihydro-3,3-dimethyl-indole-1 -carboxamide as a 5-hydroxytrypt-amine antagonist GLAXO GROUP LIMITED (GB) 1993-04-06 US disclosed
US-5190954-A 5-Hydroxytryptamine Antagonists GLAXO GROUP LIMITED (GB) 1993-03-02 US disclosed
US-5071854-A Hydroxytryptamine antagonists GLAXO GROUP LIMITED (GB) 1991-12-10 US disclosed
US-5001133-A Benzoic acid derivatives SANDOZ LTD. (CH) 1991-03-19 US disclosed
US-4985437-A 5-HYDROXYTRYPTAMINE ANTAGONISTS, COGNITION ACTIVATORS GLAXO GROUP LIMITED (GB) 1991-01-15 US disclosed
US-4973594-A TREATMENT OF DEPRESSION GLAXO GROUP LIMITED (GB) 1990-11-27 US disclosed
US-4948803-A USING AZABICYCLOINDAZOLE-3-CARBOXAMIDES GLAXO GROUP LIMITED (GB) 1990-08-14 US disclosed
WO-1988003801-A1 MEDICAMENTS FOR TREATMENT OR PREVENTION OF WITHDRAWAL SYNDROME GLAXO GROUP LIMITED (GB) 1988-06-02 WO disclosed